These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8672501)

  • 1. Enzymatic and chemical footprinting of anthracycline antitumor antibiotics and related saccharide side chains.
    Shelton CJ; Harding MM; Prakash AS
    Biochemistry; 1996 Jun; 35(24):7974-82. PubMed ID: 8672501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence selective binding of ditrisarubicin B to DNA: comparison with daunomycin.
    Fox KR; Kunimoto S
    FEBS Lett; 1989 Jul; 250(2):323-7. PubMed ID: 2753137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of daunomycin to diaminopurine- and/or inosine-substituted DNA.
    Bailly C; Suh D; Waring MJ; Chaires JB
    Biochemistry; 1998 Jan; 37(4):1033-45. PubMed ID: 9454594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of the calicheamicin gamma 1I-DNA complex.
    Kumar RA; Ikemoto N; Patel DJ
    J Mol Biol; 1997 Jan; 265(2):187-201. PubMed ID: 9020982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequence recognition by bispyrazinonaphthalimides antitumor agents.
    Carrasco C; Joubert A; Tardy C; Maestre N; Cacho M; Braña MF; Bailly C
    Biochemistry; 2003 Oct; 42(40):11751-61. PubMed ID: 14529286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of polybenzamides to DNA: studies by DNase I and chlorambucil interference footprinting and comparison with Hoechst 33258.
    Turner PR; Ferguson LR; Denny WA
    Anticancer Drug Des; 1998 Dec; 13(8):941-54. PubMed ID: 10335268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence selective binding of bis-daunorubicin WP631 to DNA.
    Fox KR; Webster R; Phelps RJ; Fokt I; Priebe W
    Eur J Biochem; 2004 Sep; 271(17):3556-66. PubMed ID: 15317591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of DNA sequence selectivity of anthracycline antibiotics and their 3'-hydroxylated analogs.
    Jollès B; Laigle A; Priebe W; Garnier-Suillerot A
    Chem Biol Interact; 1996 Mar; 100(2):165-76. PubMed ID: 8646789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence specificity in the binding of anti-tumour anthracyclines to DNA: a success of theory.
    Pullman B
    Anticancer Drug Des; 1991 May; 6(2):95-105. PubMed ID: 2039585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-binding studies of XSPTSPSZ, derivatives of the intercalating heptad repeat of RNA polymerase II.
    Harding MM; Krippner GY; Shelton CJ; Rodger A; Sanders KJ; Mackay JP; Prakash AS
    Biopolymers; 1997 Oct; 42(4):387-98. PubMed ID: 9283289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequence recognition by a novel series of minor groove-binding ligands.
    Fox KR; Yan Y; Gong B
    Anticancer Drug Des; 1999 Jun; 14(3):219-30. PubMed ID: 10500497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for the T-antigen-induced structural alteration of the SV40 replication origin based upon experiments with specific probes for bent, straight, and unwound DNA.
    Han FX; Hurley LH
    Biochemistry; 1996 Jun; 35(24):7993-8001. PubMed ID: 8672503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure by NMR of antitumor drugs aclacinomycin A and B complexed to d(CGTACG).
    Yang D; Wang AH
    Biochemistry; 1994 May; 33(21):6595-604. PubMed ID: 8204596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety.
    Capranico G; Butelli E; Zunino F
    Cancer Res; 1995 Jan; 55(2):312-7. PubMed ID: 7812964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants for DNA minor groove recognition: design of a bis-guanidinium derivative of ethidium that is highly selective for AT-rich DNA sequences.
    Bailly C; Arafa RK; Tanious FA; Laine W; Tardy C; Lansiaux A; Colson P; Boykin DW; Wilson WD
    Biochemistry; 2005 Feb; 44(6):1941-52. PubMed ID: 15697219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Footprinting studies on the interactions of nogalamycin, arugomycin, decilorubicin and viriplanin with DNA.
    Fox KR
    Anticancer Drug Des; 1988 Dec; 3(3):157-68. PubMed ID: 3207463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anthracyclines and synthetic hexanucleotides. Structural factors influencing sequence specificity.
    Rizzo V; Battistini C; Vigevani A; Sacchi N; Razzano G; Arcamone F; Garbesi A; Colonna FP; Capobianco M; Tondelli L
    J Mol Recognit; 1989 Nov; 2(3):132-41. PubMed ID: 2636902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of compound structure on affinity, sequence selectivity, and mode of binding to DNA for unfused aromatic dications related to furamidine.
    Nguyen B; Tardy C; Bailly C; Colson P; Houssier C; Kumar A; Boykin DW; Wilson WD
    Biopolymers; 2002 Apr; 63(5):281-97. PubMed ID: 11877739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide sequence of SN-07 chromophore binding site.
    Kimura K; Morinaga T; Miyata N; Kawanishi G
    J Antibiot (Tokyo); 1989 Dec; 42(12):1838-43. PubMed ID: 2621165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperativity in the binding of echinomycin to DNA fragments containing closely spaced CpG sites.
    Bailly C; Hamy F; Waring MJ
    Biochemistry; 1996 Jan; 35(4):1150-61. PubMed ID: 8573569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.